Jan 27-31 Results

Below are last week's results and notes.

Date Entry	Security	Option	Cost	Date Sold	Amount Received	Per Contract Result	% result
1/24/2020	VXX	Jan 31 $15.00 Call	0.36	1/27/2020	0.78	0.42	116.67%
1/27/2020	SPY	Jan 29 $320.00 Put	0.77	1/27/2020	0.97	0.2	25.97%
1/28/2020	AAPL	Feb 28 $400.00 Call	0.33	1/29/2020	0.1	-0.23	-69.70%
1/28/2020	FCEL	Feb 21 $2.00 Call	0.22	1/31/2020	0.12	-0.1	-45.45%
1/28/2020	VIXY	Jan 31 $14.00 Call	0.11	1/29/2020	0.06	-0.05	-45.45%
1/29/2020	SQQQ	Feb 21 $22.00 Call	0.49	1/30/2020	0.61	0.12	24.49%
						0.36	1.09%

- The VXX trade was a momentum trade on the rising Coronavirus
- The SPY trade was made using a daily chart pattern support break
- The AAPL trade was a guess on earnings reaction
- The FCEL trade was an option value trade with news likely during the week
- The VIXY trade was a lotto guess
- The SQQQ was a momentum trade on earnings reactions and Coronavirus
- Stop losses were used on all trades.
- The account grew by about 25% gain from last week   



** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like research done on a stock you own or are thinking about buying, email at kdkoptions@gmail.com **

Last Week's (Jan 21-24) Results

Hello

Below are last week's results and notes

Date Entry	Security	Option	Cost	Date Sold	Amount Received	Per Contract Result	% result
1/21/2020	FCEL	Feb $2.50 Call	0.6	1/21/2020	0.69	0.09	15.00%
1/21/2020	SPY	Jan 24 $334.5 Call	0.27	1/22/2020	0.33	0.06	22.22%
1/21/2020	TLT	Jan 25 $139.50 Call	0.59	1/22/2020	0.7	0.11	18.64%
1/22/2020	SPY	Jan 24 $332.50 Call	0.53	1/23/2020	0.15	-0.38	-71.70%
1/23/2020	SPY	Jan 24 $332.50 Call	0.34	1/24/2020	0.23	-0.11	-32.35%
1/23/2020	TLT	Jan 24 $142 Call	0.21	1/24/2020	0.06	-0.15	-71.43%
1/24/2020	SPY	Jan 27 $328 Put	0.43	1/24/2020	0.71	0.28	65.12%
						-0.1	-7.79%

Notes

- Stop pricing kept the trading moving forward. The account needs to improve its stop pricing on its profitable trades.
-There is an open VXX Jan 31 $15.00 call option trade going. We'll see how this goes.
- The FCEL trade wsa brought on by another trader's information. It also had a high premium value (20% on both ends) in relation to its stock price going into its earnings call.
- The SPY 334.5 trade was a momentum trade.
- The TLT 139.50 trade was a momentum trade
- Both SPY $332.5 trades were momentum trades
- The TLT $142 was a momentum trade
- The SPY $328 Put trade was a  momentum trade



** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like research done on a stock you own or are thinking about buying, email at kdkoptions@gmail.com **

New Call Trade With Nasdaq ETF SQQQ

A new call trade has been made in Nasdaq short ETF SQQQ. An October 18th $35.00 call has been purchased for $0.97 before fees. The goal of the trade is to see $2.00. Stop pricing has been set up. Reasons for the trade are below.

- Economic Numbers out and not looking to good
- Lots of Fed speakers next week
- Earnings

 ** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like up to the moment communication on KDK Options trades, email at kdkoptions@gmail.com **

Crispr Call Trade Ends in Profit

On July 26th the Crispr call trade ended in profit. The call options were sold for $0.65 each before fees. Some reasons for the trade are below. The original post on the trade can be found here. On to the next trade!

- Stop price hit.
- Other opportunities showing up 




 ** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like up to the moment communication on KDK Options trades, email at kdkoptions@gmail.com **

New Call Trade in Crispr Therapeutics

A new call trade has been made with Crispr Therapeutics on July 24th. Two Aug 2nd $55.00 call options were purchased for $0.78 before fees. Stop pricing has been instituted. The expectation is $1.00. Some reasons for the trade are below.

 - Earnings coming on 7/29
- Hitting $50.00 resistance


 ** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like up to the moment communication on KDK Options trades, email at kdkoptions@gmail.com **

New Call Trade in Facebook

A new call trade has been made in Facebook. The Aug 2 $222.50 call option has been purchased for $0.57 before fees and commissions. The goal of the trade is $10.00. A stop loss pricing model has been instituted. Some reasons for the trade are below.

- Earnings coming up on July 24th
- Libra announcement
- Entry into Cryptocurrency is a scale changer
- The chart has been on the 52 week high for an extended period of time


 ** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like up to the moment communication on KDK Options trades, email at kdkoptions@gmail.com **

New Spread Trade in Bank of America

There is a new spread trade in Bank of America. A Feb 1st $27.00 Call and $24.50 Put were purchased for $0.61 before fees and commissions. Stop loss pricing has been set up. Some reasons for the trade are below.

- Earnings next week
- Major resistance level reached at $26.00
- Next resistance at the gap fill of $26.73
- 50 day moving average 26.10
- 3 Month R1 and S1 are 28.90 and 22.86
- 50% price retracement up from $29.00 - $22.66 move
-  Dec 24 - Jan 14 is 100% time value extension from Dec 1 - Dec 24 downturn
- MACD (12, 26) looks toppy in 3 Month chart
- RSI at top of 3 month range


 




  ** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like up to the moment communication on KDK Options trades, email at kdkoptions@gmail.com **